CZ403592A3 - Arylcarbonylaminoalkyldihydrooxopyridines, process of their preparation and their use - Google Patents

Arylcarbonylaminoalkyldihydrooxopyridines, process of their preparation and their use Download PDF

Info

Publication number
CZ403592A3
CZ403592A3 CS924035A CS403592A CZ403592A3 CZ 403592 A3 CZ403592 A3 CZ 403592A3 CS 924035 A CS924035 A CS 924035A CS 403592 A CS403592 A CS 403592A CZ 403592 A3 CZ403592 A3 CZ 403592A3
Authority
CZ
Czechia
Prior art keywords
formula
aryl
compound
oxo
lower alkyl
Prior art date
Application number
CS924035A
Other languages
Czech (cs)
English (en)
Inventor
Heinrich Dr Englert
Dieter Dr Mania
David Dr Wettlaufer
Erik Dr Klaus
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CZ403592A3 publication Critical patent/CZ403592A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
CS924035A 1992-02-20 1992-12-31 Arylcarbonylaminoalkyldihydrooxopyridines, process of their preparation and their use CZ403592A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92102828 1992-02-20

Publications (1)

Publication Number Publication Date
CZ403592A3 true CZ403592A3 (en) 1993-12-15

Family

ID=8209352

Family Applications (1)

Application Number Title Priority Date Filing Date
CS924035A CZ403592A3 (en) 1992-02-20 1992-12-31 Arylcarbonylaminoalkyldihydrooxopyridines, process of their preparation and their use

Country Status (17)

Country Link
US (1) US5360808A (en10)
EP (1) EP0556738B1 (en10)
JP (1) JPH069560A (en10)
KR (1) KR930017895A (en10)
CN (1) CN1075480A (en10)
AT (1) ATE122659T1 (en10)
AU (1) AU3375993A (en10)
CA (1) CA2089955A1 (en10)
CZ (1) CZ403592A3 (en10)
DE (1) DE69300152D1 (en10)
FI (1) FI930716A (en10)
HU (1) HU9300463D0 (en10)
IL (1) IL104781A0 (en10)
MA (1) MA22806A1 (en10)
MX (1) MX9300915A (en10)
NO (1) NO930594L (en10)
ZA (1) ZA931185B (en10)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02006131A (es) * 1999-12-21 2002-12-16 Monsanto Technology Llc Derivados de diacilo herbicidas de propilendiamina.
DE10205219A1 (de) * 2002-02-08 2003-08-21 Bayer Ag Chinoxalinone und ihre Verwendung
US6869966B2 (en) * 2002-09-30 2005-03-22 Banyu Pharmaceutical Co., Ltd. N-substituted-2-oxodihydropyridine derivatives
US20040127129A1 (en) * 2002-12-31 2004-07-01 Shuiyuan Luo Grooved-shape monofilaments and the fabrics made thereof
US8138209B2 (en) * 2005-07-13 2012-03-20 Jenrin Discovery, Inc. Substituted picolinamides as MAO-B inhibitors useful for treating obesity
US8314087B2 (en) 2007-02-16 2012-11-20 Amgen Inc. Nitrogen-containing heterocyclyl ketones and methods of use
KR101370185B1 (ko) 2008-12-23 2014-03-05 에프. 호프만-라 로슈 아게 P2x7 조절제로서의 디히드로피리돈 아미드
CA2745866A1 (en) 2008-12-23 2010-07-01 F.Hoffmann-La Roche Ag Dihydropyridone ureas as p2x7 modulators
WO2010072597A1 (en) 2008-12-23 2010-07-01 F. Hoffmann-La Roche Ag Dihydropyridone amides as p2x7 modulators
WO2010072605A1 (en) 2008-12-23 2010-07-01 F. Hoffmann-La Roche Ag Dihydropyridone amides as p2x7 modulators
US8153808B2 (en) 2008-12-23 2012-04-10 Roche Palo Alto Llc Dihydropyridone amides as P2X7 modulators
US8816085B2 (en) 2009-08-26 2014-08-26 Takeda Gmbh Methylpyrrolopyridinecarboxamides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2637477A1 (de) * 1976-08-20 1978-02-23 Hoechst Ag Dihydro-oxo-nicotinsaeuren und verfahren zu ihrer herstellung
US4297360A (en) * 1980-03-28 1981-10-27 Sterling Drug Inc. 5-(Pyridinyl)pyridine-2,3-diamines, preparation thereof and their cardiotonic use
NZ195564A (en) * 1979-11-26 1983-09-30 Sterling Drug Inc 5-pyridinyl-2(1h)-pyridinones pharmaceutical compositions intermediate pyridine compounds
IT8367883A0 (it) * 1982-08-23 1983-08-22 Rorer Int Overseas Composti cardiotonici del 2 piridone 5 biciclico eteroaril sostituito e relative composizioni farmaceutiche
GB8809481D0 (en) * 1988-04-21 1988-05-25 Smith Kline French Lab Chemical compounds

Also Published As

Publication number Publication date
EP0556738B1 (en) 1995-05-17
IL104781A0 (en) 1993-06-10
NO930594L (no) 1993-08-23
KR930017895A (ko) 1993-09-20
AU3375993A (en) 1993-08-26
ATE122659T1 (de) 1995-06-15
JPH069560A (ja) 1994-01-18
MA22806A1 (fr) 1993-10-01
ZA931185B (en) 1993-09-16
EP0556738A1 (en) 1993-08-25
NO930594D0 (no) 1993-02-19
US5360808A (en) 1994-11-01
HU9300463D0 (en) 1993-05-28
CA2089955A1 (en) 1993-08-21
CN1075480A (zh) 1993-08-25
FI930716A (fi) 1993-08-21
DE69300152D1 (de) 1995-06-22
FI930716A0 (fi) 1993-02-18
MX9300915A (es) 1993-09-01

Similar Documents

Publication Publication Date Title
Gungor et al. Cardiotonic agents. Synthesis and cardiovascular properties of novel 2-arylbenzimidazoles and azabenzimidazoles
KR100202463B1 (ko) 아미노코우마란 유도체, 그들의 제조방법 및 용도
CA2048110C (en) Imidazopyridine derivatives and their use
KR100549804B1 (ko) 신규한 사이클릭 디아민 화합물 및 그것을 포함하는 의약
US5786355A (en) 4,6-diarylpyrimidine derivatives and salts thereof
JPH03120243A (ja) アシル補酵素a:コレステロールアシルトランスフエラーゼ(acat)阻害剤としての新規n―アリール及びn―ヘテロアリールアミド及び尿素誘導体
UA46821C2 (uk) Заміщені n-[(аміноімінометил або амінометил)феніл]пропіламіди, фармацевтична композиція, способи лікування та проміжні сполуки
FR2695126A1 (fr) Dérivés d'acide thiényl ou pyrrolyl carboxyliques, leur préparation et médicaments les contenant.
CZ403592A3 (en) Arylcarbonylaminoalkyldihydrooxopyridines, process of their preparation and their use
EP1939186A1 (en) 5-Fluorouracil derivatives and their use for the treatment of cancer
KR100511626B1 (ko) 퀴놀리논유도체의제조방법
KR19990028757A (ko) 벤조[g]퀴놀린 유도체
US20040192612A1 (en) Caspase inhibitors and uses thereof
HU198014B (en) Process for producing antiarithmic sulfonamides and pharmaceutical compositions containing them
CN110483418B (zh) 3-取代喹唑啉酮-2-甲酰胺衍生物及其制备方法和应用
JPH07267954A (ja) 新規の3−フェニルスルホニル−3,7−ジアザビシクロ[3,3,1ノナン−化合物、その製法及び抗不整脈剤
SK99298A3 (en) 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine used as medicine acting on the central nervous system
EP0430693A2 (en) Pyrimidinedione derivative compounds, method for preparing same, and antiarrhythmic agents containing same
US6660745B1 (en) Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof
JPH03178965A (ja) 心臓血管障害の治療に有用なピリドンニトリル
JPH0420916B2 (en10)
CZ284652B6 (cs) (S)-(-)-2-trifluormethyl-4-(3-kyanfenyl)-4,6,7,8-tetrahydro-5(1H)-chinolon, způsoby jeho přípravy, farmaceutické prostředky, které ho obsahují a jeho použití
RU2562773C2 (ru) Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения
JPH02288864A (ja) 4(1h)キノロン誘導体
CN115784972A (zh) 乙二胺衍生物及其制备方法与应用